Medication Nonadherence in Diabetes
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To examine the longitudinal effects of medication nonadherence (MNA) on key costs and estimate potential savings from increased adherence using a novel methodology that accounts for shared correlation among cost categories. RESEARCH DESIGN AND METHODS: Veterans with type 2 diabetes (740,195) were followed from January 2002 until death, loss to follow-up, or December 2006. A novel multivariate, generalized, linear, mixed modeling approach was used to assess the differential effect of MNA, defined as medication possession ratio (MPR) ≥0.8 on healthcare costs. A sensitivity analysis was performed to assess potential cost savings at different MNA levels using the Consumer Price Index to adjust estimates to 2012 dollar value. RESULTS: Mean MPR for the full sample over 5 years was 0.78, with a mean of 0.93 for the adherent group and 0.58 for the MNA group. In fully adjusted models, all annual cost categories increased ∼3% per year (P = 0.001) during the 5-year study time period. MNA was associated with a 37% lower pharmacy cost, 7% lower outpatient cost, and 41% higher inpatient cost. Based on sensitivity analyses, improving adherence in the MNA group would result in annual estimated cost savings ranging from ∼$661 million (MPR <0.6 vs. ≥0.6) to ∼$1.16 billion (MPR <1 vs. 1). Maximal incremental annual savings would occur by raising MPR from <0.8 to ≥0.8 ($204,530,778) among MNA subjects. CONCLUSIONS: Aggressive strategies and policies are needed to achieve optimal medication adherence in diabetes. Such approaches may further the so-called “triple aim” of achieving better health, better quality care, and lower cost.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data
Quan, H., Sundararajan, V., Halfon, P., Fong, A., Burnand, B., Luthi, J.-C., Saunders, L. D., Beck, C. A., Feasby, T. E., & Ghali, W. A. (2005) · Medical Care · doi:10.1097/01.mlr.0000182534.19832.83 · Cited by 10,669
The Triple Aim: Care, Health, And Cost
Berwick, D. M., Nolan, T. W., & Whittington, J. (2008) · Health Affairs · doi:10.1377/hlthaff.27.3.759 · Cited by 5,136
Nathan, D. M., Buse, J. B., Davidson, M. B., Ferrannini, E., Holman, R. R., Sherwin, R., & Zinman, B. (2009) · Diabetes Care · doi:10.2337/dc08-9025 · Cited by 3,834
A systematic review of adherence with medications for diabetes
Cramer, J. A. (2004) · Diabetes Care · doi:10.2337/diacare.27.5.1218 · Cited by 1,203
Interventions to Enhance Patient Adherence to Medication Prescriptions: Scientific Review
McDonald, H. P., Garg, A. X., & Haynes, R. B. (2002) · JAMA · doi:10.1001/jama.288.22.2868 · Cited by 1,176 · cited 2×
“In general, these investigators concluded that most successful methods for improving chronic medication adherence were complex, labor intensive, and not predictably effective (19).”
BackgroundReview of statistical methods for analysing healthcare resources and costs
Mihaylova, B., Briggs, A., O'Hagan, A., & Thompson, S. G. (2011) · Health Economics · doi:10.1002/hec.1653 · Cited by 767 · cited 2×
“In addition, most analyses fail to appropriately account for the shared correlation among cost variables (11).”
BackgroundDoes Free Care Improve Adults' Health?: Results from a Randomized Controlled Trial
Brook, R. H., Ware, J. E., Rogers, W. H., Keeler, E. B., Davies, A. R., Donald, C. A., Goldberg, G. A., Lohr, K. N., Masthay, P. C., & Newhouse, J. P. (1983) · New England Journal of Medicine · doi:10.1056/nejm198312083092305 · Cited by 666 · cited 1×
“This is consistent with an earlier experience in the Rand health insurance experiment (25); although we should note that our study was not designed to specifically examine the effects of copayments on medication adherence.”
ResultHanlon, J. T., Weinberger, M., Samsa, G. P., Schmader, K. E., Uttech, K. M., Lewis, I. K., Cowper, P. A., Landsman, P. B., Cohen, H. J., & Feussner, J. R. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89519-8 · Cited by 612
Impact of Recent Increase in Incidence on Future Diabetes Burden
Narayan, K. M. V., Boyle, J. P., Geiss, L. S., Saaddine, J. B., & Thompson, T. J. (2006) · Diabetes Care · doi:10.2337/dc06-1136 · Cited by 602 · cited 2×
“$100 billion spent each year on avoidable hospitalizations (1,2).”
BackgroundMiller, D. R., Safford, M. M., & Pogach, L. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.suppl_2.b10 · Cited by 425 · cited 1×
“hypoglycemic agents in 2002 based on a previously validated algorithm (12).”
Method
Cited by
Items 101–194 of 194
Hogervorst, S., Adriaanse, M. C., Brandt, H. E., Vervloet, M., van Dijk, L., & Hugtenburg, J. G. (2021) · Pilot and Feasibility Studies · doi:10.1186/s40814-021-00892-2 · Cited by 12
Murry, L. T., Murry, R. C., Deng, H., Viyyuri, B. R., Gerleman, B., & Urmie, J. M. (2020) · Journal of Pharmacy Practice · doi:10.1177/0897190020903852 · Cited by 11
Bloomgarden, Z. T., Tunceli, K., Liu, J., Brodovicz, K. G., Mavros, P., Engel, S. S., Radican, L., Chen, Y., Rajpathak, S. N., Qiu, Y., et al. (2016) · Journal of Diabetes · doi:10.1111/1753-0407.12461 · Cited by 12
Aleppo, G., Parkin, C. G., Carlson, A. L., Galindo, R. J., Kruger, D. F., Levy, C. J., Umpierrez, G. E., Forlenza, G. P., & McGill, J. B. (2021) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2021.0196 · Cited by 11
H., A. H. V. A., V, & Prabhu, S. (2022) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/2375 · Cited by 11
Sun, P., & Lian, J. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1151326 · Cited by 13
Concordance between two methods in measuring treatment adherence in patients with type 2 diabetes
López‐Simarro, F., Brotons, C., Moral, I., Aguado-Jodar, A., Cols-Sagarra, C., & Miravet-Jiménez, S. (2016) · Patient Preference and Adherence · doi:10.2147/ppa.s105073 · Cited by 15
Brown, E. A., Ward, R. C., Weeda, E. R., Taber, D. J., Axon, R. N., & Gebregziabher, M. (2019) · Health Equity · doi:10.1089/heq.2019.0071 · Cited by 10
“This cohort had been formed for an earlier study, 14 and we expanded the dataset to merge Medicare Part D data as described below.”
Self-citationPatterns of use and expenses associated with mail-service pharmacy in adults with diabetes
Wu, J., Davis–Ajami, M. L., & Noxon, V. (2014) · Journal of the American Pharmacists Association · doi:10.1331/japha.2015.14058 · Cited by 11
Ingrasciotta, Y., Vitturi, G., & Trifirò, G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13072113 · Cited by 11
“%) was associated with an increase of 41% of the total inpatient cost [62].”
BackgroundEl-Deyarbi, M., Ahmed, L. A., King, J., Abubackar, S., Juboori, A. A., Mansour, N. A., & Aburuz, S. (2024) · F1000Research · doi:10.12688/f1000research.146517.1 · Cited by 12
“Appointments were scheduled at months 3, 6, and 12 from the initial visit according to the patient ’ s preferred date, and they received a reminder phone call three days prior to the next visit by the clinic call centre.”
Mora, P. F., SUTTON, D. R., Gore, A., Baliga, B. S., Goldfaden, R. F., NIKKEL, C. C., Sink, J. H., & ADAMS-HUET, B. A. (2020) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2020-001832 · Cited by 9
Economic Evaluation of Once-Weekly Insulin Icodec from Italian NHS Perspective
Torre, E., Matteo, S. D., Bruno, G. M., Martinotti, C., Bottaro, L. C., & Colombo, G. L. (2024) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s475461 · Cited by 10
Weeda, E. R., Bishu, K. G., Ward, R. C., Brown, E. A., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2020.02.027 · Cited by 8
Self-citationFaisal, S., Ivo, J., Tennant, R., Prior, K.-A., Grindrod, K., McMillan, C., & Patel, T. (2021) · Pharmacy · doi:10.3390/pharmacy9020105 · Cited by 12
Bandiera, C., Lam, L., Locatelli, I., Dotta-Celio, J., Duarte, D., Wuerzner, G., Pruijm, M. T., Zanchi, A., & Schneider, M. P. (2022) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-022-00898-7 · Cited by 10
Tamblyn, R. M., Girard, N., Dixon, W. G., Haas, J. S., Bates, D. W., Sheppard, T., Eguale, T., Buckeridge, D. L., Abrahamowicz, M., & Forster, A. J. (2016) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2016.03.033 · Cited by 10
Medication adherence and racial differences in diabetes in the USA: an update
Adams, A. S., Banerjee, S., & Ku, C. J. (2015) · Diabetes Management · doi:10.2217/dmt.14.55 · Cited by 12
Buchanan, C. H., Brown, E. A., Bishu, K. G., Weeda, E. R., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2021) · Women s Health Issues · doi:10.1016/j.whi.2021.10.003 · Cited by 10
Self-citationChong, M. (2016) · Journal of Research in Pharmacy Practice · doi:10.4103/2279-042x.185740 · Cited by 10
Henry, R. R., Rosenstock, J., McCarthy, J. F., Carls, G. S., Alessi, T., Yee, J., & Baron, M. A. (2017) · Diabetes Obesity and Metabolism · doi:10.1111/dom.13133 · Cited by 7
Quast, T. C. (2019) · Economics of Disasters and Climate Change · doi:10.1007/s41885-019-0039-8 · Cited by 7
Edelman, S. V., Ermakova, A., Xiong, Y., Sieradzan, R., & Taylor, S. (2019) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2019.19097 · Cited by 9
Chong, M. (2020) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_19_75 · Cited by 7
Chinthammit, C., Axon, D. R., Mollon, L. E., Taylor, A. M., Pickering, M. K., Black, H. L., Warholak, T. L., & Campbell, P. J. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2021.27.1.064 · Cited by 11
Moses, A. C., Mawby, M., & Phillips, A. (2013) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2012.12.011 · Cited by 8
Sane, R. (2018) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20180302.12 · Cited by 7
“Despite the availability of numerous classes of OADs and extensively laid down guidelines, number of cases of DM are consistently increasing [12].”
BackgroundSambamoorthi, U., Garg, R., Deb, A., Fan, T., & Boss, A. (2017) · Current Medical Research and Opinion · doi:10.1080/03007995.2017.1318121 · Cited by 6
Isaacs, D. M., Kruger, D. F., SHOGER, E., & Chawla, H. (2022) · Clinical Diabetes · doi:10.2337/cd22-0034 · Cited by 6
Mendonça, I. R., Rosendo, A. B., da Silva, B. B., & Iser, B. P. M. (2023) · DEMETRA Alimentação Nutrição & Saúde · doi:10.12957/demetra.2023.70199 · Cited by 12
Abejirinde, I. O., Itanyi, I. U., Kornas, K., Zaim, R., Guha, S., Chui, V., Lipscombe, L. L., Rosella, L. C., & Shaw, J. (2025) · Journal of Participatory Medicine · doi:10.2196/69497 · Cited by 7
Rosella, L. C., Shaw, J., Guha, S., Abejirinde, I. O., Gibson, J., Lipscombe, L. L., Kornas, K., Zaim, R., Chui, V., & Itanyi, I. U. (2025) · Digital Health · doi:10.1177/20552076251358541 · Cited by 6
Meo, N., Wong, E. S., Sun, H., Curtis, I., Batten, A. J., Fihn, S. D., & Nelson, K. M. (2017) · Population Health Management · doi:10.1089/pop.2017.0039 · Cited by 4
Santoleri, F. (2014) · International Journal of Pharmaceutical Sciences Research · doi:10.15344/2394-1502/2014/101 · Cited by 3
Ntyonga-Pono, M.-P. (2015) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(15)30043-2 · Cited by 12
Association of Visit-to-Visit Variability of Hemoglobin A1c and Medication Adherence
Ramachandran, A., Winter, M. R., & Mann, D. M. (2015) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2015.21.3.229 · Cited by 4
Corrao, G., Rea, F., Mancia, G., Perseghin, G., Merlino, L. G., Martini, N., Carbone, S., Carle, F., Bucci, A., Carle, F., et al. (2021) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2021.07.014 · Cited by 5
Ghang, H., & Lee, J. (2023) · Journal of Preventive Medicine and Public Health · doi:10.3961/jpmph.23.252 · Cited by 4
Guideline Development for Medical Device Technology: Issues for Consideration
Battelino, T., Brosius, F. C., Ceriello, A., Cosentino, F., Green, J., Kellerer, M., Koob, S., Kosiborod, M., Lalic, N. M., Marx, N., et al. (2022) · Journal of Diabetes Science and Technology · doi:10.1177/19322968221093355 · Cited by 5
Elayyan, B., Abuhalima, D., Al‐Jabi, S. W., & Zyoud, S. H. (2025) · BMC Endocrine Disorders · doi:10.1186/s12902-025-02000-4 · Cited by 5
Liu, X., Varshney, U., & Li, P. (2025) · Journal of the American Medical Informatics Association · doi:10.1093/jamia/ocaf199 · Cited by 5
Quality Assessment of Smartphone Medication Management Apps in France: Systematic Search
Toïgo, M., Marc, J., Hayot, M., Moulis, L., & Carbonnel, F. (2024) · JMIR mhealth and uhealth · doi:10.2196/54866 · Cited by 5
Asiamah-Asare, B. K. Y., Randall, S. M., Mnatzaganian, G., Varhol, R., Lee, C., Chai, K. E. K., Boyd, J., Cowen, G., Shakya, S., Gao, L., et al. (2025) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2025.103302 · Cited by 7
Santoleri, F., Sorice, P., Lasala, R., & Costantini, A. (2014) · Pharmacology & Pharmacy · doi:10.4236/pp.2014.54040 · Cited by 3
Franch‐Nadal, J., García-Gollarte, F., del Molino, A. P., Peña, M. L. O., de Miguel, M. R., Klinkas, M. M., de Paz, H. D., Aceituno, S., & Rodríguez‐Fortúnez, P. (2018) · Clinical Drug Investigation · doi:10.1007/s40261-018-0713-6 · Cited by 3
Kamga, A. M., Martino, C. D., Anota, A., Paget‐Bailly, S., Coutant, C., Arveux, P., Desmoulins, I., & Dabakuyo‐Yonli, T. S. (2020) · Trials · doi:10.1186/s13063-020-04397-w · Cited by 3
Ward, R. C., Weeda, E. R., Bishu, K. G., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020) · Journal of Managed Care & Specialty Pharmacy · doi:10.18553/jmcp.2020.26.9.1090 · Cited by 3
Self-citationMajd, Z., Chen, H., Johnson, M. L., Birtcher, K. K., Serna, O., Fatima, B., & Abughosh, S. (2025) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2025.109080 · Cited by 2
Ofori‐Asenso, R., Ilomäki, J., Chin, K. L., Mazidi, M., Zomer, E., Bell, J. S., Magliano, D. J., & Liew, D. (2019) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2019.107909 · Cited by 2
Vasa, D., Guerra, L., Goel, M. S., Harris, Y., & Lin, J. J. (2024) · Psycho-Oncology · doi:10.1002/pon.9309 · Cited by 2
Are newer insulins always the better option?
Malkani, S. (2019) · Current Opinion in Endocrinology Diabetes and Obesity · doi:10.1097/med.0000000000000469 · Cited by 2
Medicines adherence in people with diabetes and disability, and the role of insulin delivery devices
Courtenay, M., Carrier, J., & Bodman, S. (2015) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 3
Shane‐McWhorter, L., McAdam‐Marx, C., Lenert, L. A., Petersen, M. J., Woolsey, S., Coursey, J. M., Whittaker, T. C., Hyer, C., LaMarche, D., Carroll, P., et al. (2016) · Diabetes Spectrum · doi:10.2337/diaspect.29.2.121 · Cited by 3
“Nonadherence is very costly (9), and savings of $5 billion annually are possible with improved medication adherence on the part of non-Hispanic and Hispanic patients alike.”
BackgroundChen, J., Kao, C. Y., He, X., Fan, L., Jackson, J. A., & Juneja, R. (2020) · Diabetes Spectrum · doi:10.2337/ds19-0060 · Cited by 2
Sadeq, A. S., Elnour, A. A., Hamrouni, A., Baraka, M. A., Meslamani, A. Z. A., Adel, A., Alkaabi, M., Ibrahim, O. M., & Mazrouei, N. A. (2021) · Journal of Pharmaceutical Health Services Research · doi:10.1093/jphsr/rmab005 · Cited by 4
Lastretti, M., Tomai, M., Visalli, N., Chiaramonte, F., Tambelli, R., & Lauriola, M. (2021) · Sustainability · doi:10.3390/su132313182 · Cited by 4
Hussain, S. A., Al-Tukmagi, H., Abdulrahman, Z. S., SADEQ, M. M., HASHİM, D. N., KADHİM, R. S., Kubba, M. M., & Tukmagi, D. A. (2021) · Istanbul Journal of Pharmacy · doi:10.26650/istanbuljpharm.2021.870571 · Cited by 3
Mitigating the Burden of Type 2 Diabetes: Challenges and Opportunities.
(2015) · PubMed · Cited by 2
Ward, R. C., Taber, D. J., Axon, R. N., & Gebregziabher, M. (2018) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2178 · Cited by 4
Self-citationLi, L., Zhang, X., Zhang, T., Zeng, L., Lin, M., Li, Y., & Li, W. (2024) · Patient Preference and Adherence · doi:10.2147/ppa.s446855 · Cited by 2
Sadamoto, K., Morio, Y., Ura, H., & Kubota, K. (2025) · Patient Preference and Adherence · doi:10.2147/ppa.s561772 · Cited by 1
Zhou, J., Lee, D. A., Talebi, Y., Wu, G., & Wu, H. (2026) · American Journal of Ophthalmology · doi:10.1016/j.ajo.2026.02.003 · Cited by 1
Araújo, L. D. C., Lourenço, V. D. S., Fagundes, V. D. C., de Oliveira, A. F., Prete, A. C. L., Ribeiro, C. H. M. A., Sarges, É. D. S., Margalho, L. P., Paixão, P. A. R., Dornas, S. G. B., et al. (2026) · Pharmacoepidemiology · doi:10.3390/pharma5030020 · Cited by 1
“Emerging evidence suggests that adequate adherence does not always translate into optimal metabolic control, indicating the influence of additional factors such as clinical complexity, therapeutic regimens, health literacy, and social determinants of health [11,12].”
Costs and Use of Oral Anti-cancer Medications among Senior Medicare Part D Beneficiaries
Kaisaeng, N. (2012) · VCU Scholars Compass (Virginia Commonwealth University) · doi:10.25772/c9jq-sn29 · Cited by 1
Case Studies in Insulin Therapy: The Last Arrow in the Treatment Quiver
Thukral, A., Selvan, C., Chakraborty, P. P., Roy, A., Goswami, S., Bhattacharjee, R., Ghosh, S. K., Mukherjee, S., & Chowdhury, S. (2013) · Clinical Diabetes · doi:10.2337/diaclin.31.4.175 · Cited by 1
Omerza, K. E. (2015) · OhioLink ETD Center (Ohio Library and Information Network) · Cited by 1
Kobayashi, D., Koyanagi, K., Kubota, T., Sakamoto, Y., Kihara, T., Miisho, T., Kasaki, T., Kunitake, M., Takeshita, F., Ando, E., et al. (2018) · YAKUGAKU ZASSHI · doi:10.1248/yakushi.18-00027 · Cited by 1
An assessment of physician reasons for prescribing Insulin Lispro 200 units/ml in Germany
Chen, J., Perez‐Nieves, M., de Oliveira, C. P., Spaepen, E., Osumili, B., Poon, J. L., Schloot, N. C., Lara, N., Alvarez, L. G., & Roset, M. (2020) · Postgraduate Medicine · doi:10.1080/00325481.2020.1805968 · Cited by 1
Hospital-Care Utilization and Medical Cost Patterns Among Patients With Insulin-Dependent Diabetes
Alkhaddo, J. B., Zhou, L., Rossi, C., Moheet, A. A., Sonon, K. E., Rayl, K. R., & Holmstrand, E. C. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.008 · Cited by 1
A technological framework based on automatic messaging for improving adherence of diabetic patients
Fioravanti, A. (2016) · UPM Digital Archive (Technical University of Madrid) · doi:10.20868/upm.thesis.39361 · Cited by 1
Adherence to antihyperglycemic treatment: a work in progress
Τζιόμαλος, Κ. (2016) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2016.1202922 · Cited by 1
Will Inhalable Insulin Reduce Medication Nonadherence With Insulin Among People With Diabetes?
Ryan, J. (2014) · Clinical Therapeutics · doi:10.1016/j.clinthera.2014.07.006
Seguimento farmacoterapêutico a idosos em um ambulatório público de Brasília
de Oliveira, M. P. F. (2015) · RIUnB Institutional Repository (University of Brasília) · doi:10.26512/2015.09.t.18793
SEGUIMENTO FARMACOTERAPÊUTICO A IDOSOS EM UM AMBULATÓRIO
Brasília, P. D. (2015)
Informing the Design of a Smartphone-Based Telemonitoring System for Multiple Chronic Conditions
Sultan, M. (2016) · TSpace (University of Toronto)
Arafat, Y. I. (2016) · Qatar University QSpace (Qatar University)
Khairnar, R. R. (2017) · ProQuest Demo Repository
Spital, U. A. E., & Khadija, R. (2018) · International Journal of Advanced Research · doi:10.21474/ijar01/6445
“…more than one half of the T2D population, and can incur significant health and economic burdens including inadequate glycemic control, higher medical cost of treatment, increased use of healthcare resources, and higher mortality rates (Egede et al., 2014a, Egede et al., 2012b, DiBonaventura, 2014).”
BackgroundHome Blood Glucose Monitoring and Digital-Health in Diabetes
Farmer, A. A., & Pal, K. (2018) · Endocrinology · doi:10.1007/978-3-319-27317-4_13-1
McGovern, A. P. (2018) · Surrey Research Insight Open Access (The University of Surrey)
Role of comprehensive diabetes care in known diabetes patients from Gujarat state
Sane, R. M., Mandole, R. S., Amin, G., Ghadigaokar, P., Paranjape, S., Khan, S. M., Sali, S., Joshi, V., & Chhatrodiya, K. (2020) · International Journal of Advances in Medicine · doi:10.18203/2349-3933.ijam20203604
“Thus, it is need of the hour to search for effective alternate therapy which will be devoid of shortcomings of conventional therapy.(7)”
BackgroundHome Blood Glucose Monitoring and Digital-Health in Diabetes
Farmer, A. A., & Pal, K. (2018) · Endocrinology · doi:10.1007/978-3-319-45015-5_13
Impact of Myo B Basti on Type 2 Diabetes Mellitus Patients with Low Body Mass Index
Sane, R. M., Mandole, R. S., Amin, G. A., & Gupta, H. (2023) · International Journal of Diabetes and Endocrinology · doi:10.11648/j.ijde.20230801.13
What is Duodenal Mucosal Resurfacing?
Cha, B. (2024) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2024.075
ADHERENCE TO ORAL ANTIDIABETIC DRUGS IN PEOPLE WITH TYPE 2 DIABETES
Holdt‐Caspersen, N. S. (2025) · VBN Forskningsportal (Aalborg Universitet) · doi:10.54337/aau784097848
Aje, A. A., & Aroyewun, M. O. (2025) · Discover Endocrinology and Metabolism · doi:10.1007/s44417-025-00008-x
Tang, T., Stoecker, C., Winberg, D., Liu, M., Nauman, E., Cong, M., Price‐Haywood, E. G., Mohundro, B. L., Bazzano, A. N., Shi, L., et al. (2025) · Value in Health · doi:10.1016/j.jval.2025.07.017
Kuwabara, Y., Taniguchi, S., Hosoda-Urban, T., Son, D., Kinjo, A., Kim, H., Kaneda, Y., & Osaki, Y. (2025) · BMJ Open · doi:10.1136/bmjopen-2025-103345
Selvan, C., Nagendra, L., Jethwani, P., Mittal, S., Kalra, S., Mondal, S., Lathia, T. B., Gupta, A. K., Gadia, S., & Anthuvan, T. (2025) · Cureus · doi:10.7759/cureus.95473
Societal Impact of Smart Pillboxes
Narayana, P. L., Sharma, A., -, S., Singh, S., & Sharma, S. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810696125010005
Hogervorst, S., Adriaanse, M., Brandt, H. E., Vervloet, M., van Dijk, L., & Hugtenburg, J. G. (2021) · Figshare · doi:10.6084/m9.figshare.15128202
Weeda, E. R., Bishu, K. G., Ward, R. C., Axon, R. N., Taber, D. J., & Gebregziabher, M. (2020) · Figshare · doi:10.6084/m9.figshare.13100913
Self-citation
Metadata
- Authors
- Egede, L. E., Gebregziabher, M., Dismuke, C. E., Lynch, C. P., Axon, R. N., Zhao, Y., & Mauldin, P. D.
- Affiliations
- Medical University of South Carolina (US)
- Corresponding author
- Egede, Leonard E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2012-11-14
- Volume
- 35
- Issue
- 12
- Pages
- 2533-2539
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3507586
- OpenAlex
- W2147325147
- Cited by
- 195
- References
- 33
- Citations by year
- 2026: 2 · 2025: 14 · 2024: 13 · 2023: 7 · 2022: 9 · 2021: 17 · 2020: 23 · 2019: 15 · 2018: 20 · 2017: 12 · 2016: 17 · 2015: 16 · 2014: 20 · 2013: 9 · 2012: 1
- FWCI
- 12.70
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Health Services Research and Development
- Topics
- Health Sciences › Medicine › Family Practice › Medication Adherence and Compliance
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Education
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- medication non-adherence, type 2 diabetes, health care costs, medication possession ratio, cost reduction, veterans, hospital costs, outpatient costs, pharmacy costs, generalized linear mixed models, Triple Aim
- MeSH terms
- Diabetes Mellitus, Type 2, Humans, Hypoglycemic Agents, Models, Statistical, Drug Monitoring, Cost Savings
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.